Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hebei Kiwa Huaxing Bio-Pharmaceuticals is a Chinese biotechnology company focused on the development and production of veterinary medicines and anti-viral agents. Established in 2008 as a joint venture between Kiwa Bio-Tech Products Group Corporation and Shijiazhuang Huaxing Animal Medicine, the company specializes in solutions for animal health, particularly for poultry and livestock. Its flagship product, AF-01, is an anti-viral aerosol technology designed to combat avian influenza and other RNA-based viral infections. The company operates manufacturing facilities in Shijiazhuang, Hebei Province, which are compliant with Chinese GMP standards. By integrating advanced bio-technological research with established pharmaceutical distribution networks, Hebei Kiwa Huaxing aims to address significant challenges in the agricultural and veterinary sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hebei Kiwa Huaxing Bio-Pharmaceuticals.